ArticleHeliyon2024
Threshold hemoglobin level for delayed cerebral ischemia: A single-center retrospective analysis.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Data-Driven Analysis of Systemic Indicators Linking Stroke-Associated Pneumonia, Delayed Cerebral Ischemia, and Outcome After Aneurysmal Subarachnoid Hemorrhage.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Delayed cerebral ischemia (DCI) occurs in approximately 20%-30 % of patients with subarachnoid hemorrhage (SAH). This is the most common complication of SAH and has a high mortality rate. In the present study, we investigated the relationship between hemoglobin (Hb) values and DCI and aimed to determine a cutoff Hb value to be used as a predictor of DCI. Methods: A total of 259 patients who were followed up for aneurysmal SAH at the Neurosurgery Clinic of Health Sciences University Dışkapı Yıldırım Beyazıt Training and Research Hospital were included in our study. The patients were categorized into three groups according to Hb levels, low: <10 g/dl, moderate:10-13 g/dl, and high: >13 g/dl, and the relationship between Hb value and DCI and clinical outcomes was examined. Further, the cutoff Hb value for predicting DCI was determined by receiver operating characteristics (ROC) curve analysis. Results: Statistical analyses revealed that patients with low Hb levels of <10 g/dl had a higher frequency of DCI than those with Hb levels of <10.75 g/dl. In addition, pairwise analyses based on the determined cutoff value revealed that patients with Hb levels <10.75 g/dl experienced DCI more frequently. Conclusion: This study aimed to determine the utility of Hb levels as a predictor of DCI by examining its risk factors. The cutoff Hb level determined here is an important predictive factor for DCI, and the results provide promising evidence in term of early detection of DCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.